StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) income statement

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.14−0.41 (-26.45%)

Close on Nov 19, 2026Market cap $8.20MP/E 0.8Yield –

Chemomab Therapeutics Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-69.5%

Financial strength

Current ratio
6.41
Debt to equity
–
Debt to assets
–
Cash to current liabilities
386.3%

Valuation

P/E ratio
0.8
Price to sales
–
Price to book
0.94
Dividend yield
–

See a number that looks wrong?